Medical Marijuana Research Act of 2017

mj_researchRepresentatives Andy Harris, M.D. (R-MD-01), Earl Blumenauer (D-OR-03), H. Morgan Griffith (R-VA-09), and Zoe Lofgren (D-CA-19) introduced H.R. 3391: The Medical Marijuana Research Act of 2017.

This Act amends the federal law to facilitate clinical investigations involving the use of cannabis and cannabis-derived products.

As you may know, there are many benefits to medical cannabis. Those suffering from PTSD, Tourette’s Syndrome, Parkinson’s Disease, and many other debilitating conditions have found relief because of medical marijuana.  

But, despite the fact that over 200 million Americans now have legal access to some form of medical marijuana, present regulations make clinical investigations involving cannabis needlessly onerous. Passage of this measure would expedite federal reviews of clinical protocols, provide greater access to scientists who wish to study the drug, and mandate an FDA review of the relevant science.

Please click HERE to contact your Representative and urge him/her to support this important measure.

 

Vote Expected Tomorrow On Medical Marijuana

Medical marijuanaTomorrow, the Senate Appropriations Committee will have to decide: Will they protect our nation’s 2 million lawful medical marijuana patients or subject them to the wrath of Attorney General Jeff Sessions?

The amendment they will be debating, known as Rohrabacher-Blumenauer, simply prevents the United States Department of Justice from spending any of our tax dollars enforcing federal marijuana prohibition against the 30 states which have now, or are in the process of, implementing a medical cannabis system.

Tell your Senators to protect patients by supporting the Rohrabacher-Blumenauer Amendment

There is NO moral reason to punish qualified patients and veterans from accessing marijuana for its therapeutic effects. Recently released data has revealed that the enactment of medical cannabis access is associated with lower rates of opioid abuse and mortality, and does not negatively impact workplace safety, teen use rates, or motor vehicle safety.

Yet, in a letter to members of Congress on May 1, Sessions demanded the end of Rohrabacher-Blumenauer, citing: “The Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.”

This is the delusional leadership we have coming out of the Justice Department. A man who equates those suffering from PTSD, cancer, AIDS, and other dire medical conditions to members of violent drug cartels.

We cannot allow Jeff Sessions to be the only one communicating with Congress. SEND A MESSAGE TO YOUR SENATORS NOW.

Massachusetts: Medical Marijuana Patients’ Afforded Workplace Protections, High Court Rules

marijuana_gavelState-registered medical cannabis patients may sue a private employer for discrimination if they are fired for their off-the-job marijuana use, according to a first in the nation ruling issued today by the Massachusetts Supreme Judicial Court.

Opining for the court, Chief Justice Ralph Gants determined that it is “not facially unreasonable” for employers to make exceptions to their substance abuse policies in instances where employees are using cannabis at home to treat a debilitating condition. “The fact that the employee’s possession of medical marijuana is in violation of federal law does not make it per se unreasonable as an accommodation,” he wrote.

The defendant in the case was fired on her first day on the job for testing positive for carboxy-THC on a company drug test. The former employee possessed a doctor’s recommendation to use cannabis to treat symptoms of Crohn’s disease and irritable bowel syndrome. Qualified patients may legally obtain cannabis in Massachusetts under a 2012 voter-initiated law.

The unanimous verdict reverses a lower court decision and is contrary to rulings in California, Colorado, Oregon, and Washington. In each of those states, the supreme courts ruled that employees had no legal protections if they were fired without cause for their state-sanctioned use of medical cannabis.

“Patients should never have to choose between their heath and their job and for the first time, a court has acknowledged that they shouldn’t have to do so,” NORML Executive Director Erik Altieri said. “It is our hope that courts in other jurisdictions begin to apply this same rationale to patients as well as to all adults who are using cannabis responsibly off-the-job in compliance with the laws of their states.”

The case is Barbuto v. Advantage Sales and Marketing LLC.

Canada should continue with separate medical stream after cannabis is legalized for recreational use: Study

After cannabis is legalized, Canada should continue with a separate medical cannabis stream to keep patients safe, argues a new commentary.

Senate Committee Overwhelmingly Passes Veterans Equal Access Amendment

Marijuana medicineToday, the Senate Appropriations Committee voted 24-7 to include the Veterans Equal Access amendment as part of the 2018 Military Construction, Veterans Affairs and Related Agencies Appropriations bill, which would expand much needed medical marijuana access to our nation’s veterans.

Presently, V.A. doctors in states where cannabis therapy is permitted are forbidden from providing the paperwork necessary to complete a medical cannabis recommendation, thus forcing military veterans to seek the advice of a private, out-of-network physician.

Veterans are increasingly turning to medical cannabis as an effective alternative to opioids and other conventional medications to treat conditions like chronic pain and post-traumatic stress. A retrospective review of patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction on a scale of post-traumatic symptom scores following cannabis therapy. This is why, in recent months, two of the largest veterans’ rights groups — AMVETS and the American Legion —  have resolved in favor of patients’ access to cannabis therapy.

The amendment was introduced by Senator Daines, R-Montana for the second year in a row. Last year, majorities in both the US House and Senate voted to include similar language as part of the Fiscal Year 2017 Military Construction, Veterans Affairs and Related Agencies Appropriations bill. However, Republicans sitting on the House Appropriations Committee elected to remove the language from the bill during a concurrence vote.

The 24-7 roll call was an increase over last years 20-10 appropriations passage. The changes came from Senators Susan Collins (R-ME), Senator John Hoeven (R-ND) and Jerry Moran (R-KS) all voting “aye” after having voted against the effort last year and both new members of the committee, Senators John Kennedy (R-LA) and Joe Manchin (D-WV) voting in favor.

Identical language is expected to receive a vote in the House later this year. Keep an eye on NORML’s Act page for that and other changes.

Tell the Senate to Expand Veterans’ Access to Medical Cannabis

Medical marijuana

 

Update: The Senate Appropriations Committee voted 24-7 to include the amendment as part of the 2018 MilCon-VA bill. It is expected that an identical amendment will be introduced in the future in the House. 

This Wednesday, July 12th, members of the Senate Appropriations Committee will convene to discuss the Military Construction, Veterans Affairs and Related Agencies Appropriations bill. This legislative debate provides lawmakers with the opportunity to expand much needed medical marijuana access to our nation’s veterans.

Presently, V.A. doctors in states where cannabis therapy is permitted are forbidden from providing the paperwork necessary to complete a medical cannabis recommendation, thus forcing military veterans to seek the advice of a private, out-of-network physician. This issue can be solved by the approval of the Veterans Access Amendment, which ends these cruel and unnecessary restrictions on V.A. doctors and their patients.

Send a message to your Senators NOW demanding equal access for veterans.

Last year, majorities in both the US House and Senate voted to include similar language as part of the Fiscal Year 2017 Military Construction, Veterans Affairs and Related Agencies Appropriations bill. However, Republicans sitting on the House Appropriations Committee elected to remove the language from the bill during a concurrence vote. We must not allow a similar outcome again this year.

Veterans are increasingly turning to medical cannabis as an effective alternative to opioids and other conventional medications to treat conditions like chronic pain and post-traumatic stress. A retrospective review of patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction on a scale of post-traumatic symptom scores following cannabis therapy. This is why, in recent months, two of the largest veterans’ rights groups — AMVETS and the American Legion —  have resolved in favor of patients’ access to cannabis therapy.

Our veterans deserve the option to legally access a botanical product that is objectively safer than the litany of pharmaceutical drugs it could replace.

Write your Senator RIGHT NOW and urge them to support the Veterans Equal Access Amendment!

Thanks for all you do,
The NORML Team

P.S. Have you gotten your ticket for the 2017 NORML D.C. Conference and Lobby yet? Click here to register and come to Washington, DC September 10th-12th. 

DEA Reaffirms Stance That CBD Meets Schedule I Criteria — Reality Says Otherwise

oil_bottlesThe US Drug Enforcement Administration has publicly reiterated its position that cannabidiol, a non-psychotropic cannabinoid, is properly categorized under federal law as a schedule I controlled substance — meaning that, by definition, it possesses “a high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and lacks “accepted safety … under medical supervision.”

The agency has long contended that CBD, along with all organic cannabinoids, is — by default — a schedule I controlled substance because it is a naturally occurring component of the cannabis plant. (This position is similarly held by both the NIDA and the FDA.) Nonetheless, a growing body of science undermines the notion that CBD meets any of the criteria necessary for such classification.

Specifically, clinical trial data finds that CBD is “safe,” “non-toxic,” and “well tolerated” in human volunteers. Even the director of the US National Institute on Drug Abuse acknowledges that CBD is “not mind-altering” and that it “appears to be a safe drug with no addictive effects.”

Recently conducted controlled studies also acknowledge its therapeutic efficacy, particularly the ability of CBD dosing to mitigate treatment-resistant seizures, hypertension, and psychotic symptoms in humans. Other peer-reviewed data shows that CBD therapy holds promise for the treatment of “Parkinson’s disease, Alzheimer’s disease, cerebral ischemia, diabetes, rheumatoid arthritis, other inflammatory diseases, nausea and cancer.”

That is why in addition to the thirty states that presently recognize medical cannabis, an additional 16 states also explicitly recognize the use of CBD as a viable medical treatment.

Nonetheless, it remains unlikely that the DEA is going to amend its position any time soon. Further, police in recent months have begun initiating raids of CBD retailers, such as those reported here, here, and here. That is why it is critical that members of Congress move forward with legislation to remove the cannabis plant from the Controlled Substances Act.

Presently, several pieces of federal legislation are pending to amend the federal classification of CBD as a schedule I substance. These include:

HR 2020: Passage of this act would exclude CBD from the federal definition of ‘marihuana.’

S. 1374/HR 2920: Passage of these Acts would exempt from federal prosecution those who are engaged in state-sanctioned medical cannabis activities; it would also remove CBD from the federal definition of ‘marihuana.’

HR 2273/S. 1008: Passage of these Acts would exclude CBD and CBD-rich cannabis plants from the federal definition of ‘marihuana.’

You can contact your members of Congress in support of these bills and other pending legislation by visiting NORML’s Take Action Center here.

Florida: Lawsuit Filed Challenging Medical Cannabis Smoking Ban

cannabis_pillsRepresentatives of Florida for Care filed litigation today challenging a statewide ban on medical cannabis smoking. The suit was expected after lawmakers approved legislation (SB 8A) in June amending Amendment 2 — a voter initiated constitutional amendment permitting the use and distribution of medical cannabis. Seventy-one percent of voters approved the amendment in November.

Senate Bill 8A amends the definition of medical cannabis in a manner that prohibitsmarijuana in a form for smoking” and that bars the personal possession of herbal cannabis flowers, except in instances where they are contained “in a sealed, tamper-proof receptacle for vaping.” The Florida for Care suit argues that these changes inconsistent with the constitutional definition of marijuana, as passed by voters, and therefore should not be implemented.

The lawsuit argues, “Inhalation is a medically effective and efficient way to deliver tetrahydrocannabinol (THC), and other cannabinoids, to the bloodstream. … By redefining the constitutionally defined term ‘medical use’ to exclude smoking, the Legislature substitutes its medical judgment for that of ‘a licensed Florida physician’ and is in direct conflict with the specifically articulated Constitutional process.”

Under the revised law, patients diagnosed with cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn’s disease, Parkinson’s disease, or multiple sclerosis — or who suffer from chronic pain related to any of these diseases — are eligible to receive a 70-day supply of cannabis-infused oils or edible products from a limited number of state-licensed dispensing facilities.

NORML has long argued against regulations that limit or prohibit patients’ access to whole-plant cannabis in lieu of cannabis-derived extracts or pills. Cannabis inhalation is not associated with increased instances of lung cancer, COPD, or other tobacco-related adverse effects on pulmonary function. Inhaled cannabis is fast acting and permits patients to accurately self-regulate their dose. By contrast, non-herbal forms of cannabis possess delayed onset and their effects can often be far less predictable than those of herbal cannabis. Many patients seeking rapid relief of symptoms do not benefit from pills, tinctures, or edibles, and such restrictions unnecessarily limit patients’ choices.

If the court invalidates SB 8A, the task of writing the rules for implementing the initiative — which must be operational by October — will fall to the Florida Department of Health.

Two New Virginia Laws Foreshadow Larger Cannabis Policy Changes

A common cliché for overcoming a difficult obstacle asks, “how do you eat an elephant?” The answer is, “one bite at a time.” In Virginia politics, the tough question facing cannabis policy reform advocates is, “how do you change the minds of political Elephants?” The answer is, “one law at a time.” Although progress in cannabis reform has been slow in Virginia, two recent bills signed by Governor Terry McAuliffe are significant signs that change is coming, and quicker than ever before.

Ending Automatic Driver’s License Suspension for Cannabis Possession

In May 2017, Gov. McAuliffe had a signing ceremony for Senator Adam Ebbin’s Senate bill 784 and Delegate Les Adams’ House bill 2051. These companion bills ended the absolute requirement that Virginians convicted of marijuana possession lose their driver’s license. Until this change, which takes effect July 1, the judge had no option but to suspend, even if the offense was totally unrelated to a vehicle. A driver’s license is necessary in commuter-based economies such as Virginia, where most residents work, attend school, receive medical treatment, or worship outside of their home city, and the public transportation is less then reliable.

Virginia NORML led the lobbying for this bill, and helped sway lawmakers in the General Assembly who were wary of the proposed changes. The legislators were convinced by explaining the law in detail, and highlighting the positive results from allowing individuals to maintain their license for work and education – no extreme rhetoric or exaggeration needed. Ryan Johnson, membership coordinator for Virginia NORML, testified for both pieces of legislation was congratulated by many thankful legislators at the ceremony.

McAuliffe_Johnson.jpg

Gov. Terry McAuliffe (VA-D) and Ryan Johnson

Johnson_Adams.jpg

Ryan Johnson with Delegate Les Adams (R-16)

“With Virginia NORML’s guidance, I was able to craft impactful testimony, helping pass meaningful legislation that will make a difference for thousands of Virginians,” said Ryan Johnson at Gov. McAuliffe’s ceremony. “I was humbled by how many legislators thanked me for stepping outside of my comfort zone and sharing my story in the 2017 General Assembly.” 

Johnson_group.jpg

Del. Paul Krizek (D-44), Del. Les Adams (R-16) ,Sen. Scott Surovell (D-36), Del. Alfonso Lopez (D-49), Ryan Johnson, Sen. Adam Ebbin (D-30)

Watch the video

The new law is a significant step for cannabis policy reform in Virginia for two reasons. First, this is one of the very few marijuana-related criminal justice reforms that advocates have successfully pushed through the difficult, Republican-controlled House subcommittees. Those subcommittees are the sticking point for most criminal justice reform legislation, the bottle neck that prevents bills from proceeding to a full House vote. Second, this is important because it allows judges discretion to apply the standard first-offender’s program and community service to an adult discovered possessing cannabis somewhere completely removed from any vehicles. Admittedly, this is a small step. However, every step, even the very small ones, put Virginia closer to a more sensible criminal justice system that does not criminalize marijuana possession or consumption.

Welcome to the Medical Cannabis States Club, Virginia

In June 2017, Gov. McAuliffe had another bill signing ceremony, this one for Senator Marsden’s Senate bill 1027. This bill is significant because it officially makes Virginia a medical cannabis state. Medical cannabis dispensaries will be called “pharmaceutical processors,” and will become medical cannabis patients’ legal source of the cannabis oil permitted under Virginia law. The processors will be vertically integrated facilities. That means the plants will be grown, cured, and trimmed onsite; all extraction, distillation, and synthesis of custom biopharmaceutical medicines will be done in the on-site laboratory; and, finally, patients will interact with and receive medication from a pharmacist. Unlike the medical cannabis dispensaries in Colorado, this will more closely resemble a traditional pharmacy.

Virginia families were instrumental in getting this landmark legislation passed. However, despite the great success, the law has serious shortcomings. There will only be five (5) pharmaceutical processors. This places a huge burden on applicants, financially and logistically, and could result in the exclusion of start-up ventures owned by minorities, women, and veterans without access to large capital resources. Second, the related laws allowing patient access to medical cannabis is very short: one (1). Only one patient group, those with intractable epilepsy, can possess medical cannabis oil. The major legislative goal for the 2018 session is the “Let Doctors Decide” bill, which would end the eugenics-style creation of state-permitted patient groups and instead allow trained medical professionals to decide if cannabis would be effective for the individual patient’s treatment plan. Jenn Michelle Pedini was at the ceremony representing Virginia NORML, and spoke to the families of several epilepsy patients and lawmakers who had supported the bill.

SB701.jpg

Sen. Dave Marsden (D-37) and many families watch as Gov. McAuliffe signs historic medical cannabis legislation. Photo courtesy Michaele White, Governor’s Office.

“It was an exciting day for the families who spent hours at the General Assembly gaining support for this bill which passed unanimously in both the House and Senate. We are looking forward to continuing this path next year and expanding the current law to include all patients for whom medical cannabis would provide relief,” said Beth Collins, Senior Director Government Relations and External Affairs at Americans for Safe Access, and mother of a child with intractable epilepsy.

These landmark bills are significant signs of the change coming in Virginia’s cannabis policy. Decriminalization is being studied by the State Crime Commission, following a request by Senate Majority leader Tommy Norment. The Driver’s License bill may be the first overly punitive prohibition measure to fall, and like dominoes, the changes to criminal justice reform will gain momentum and culminate in decriminalization of adult cannabis possession within the next couple years. The pharmaceutical processor bill is a huge hurdle for both patients seeking legal access to medical cannabis medications, and for individuals interested in the regulated cannabis industry. Although Virginia’s cannabis industry will fall under heavy regulation and oversight by the Commonwealth, the new industry presents new opportunities, jobs, and tax revenue.

Virginia NORML is the leading cannabis law reform organization in Virginia, but we can only continue our success in changing outdated laws with your help! The Summer of Change Campaign is currently underway, and we are trying to raise $42,000 to support our efforts in the 2018 session and the push for “Let Doctors Decide.” Virginia has a major election this year, and the outcome could determine the success – or failure – of our efforts. Donate today to the Summer of Change campaign! With your help, Virginia NORML will continue its track record of success in Richmond bringing marijuana policy reform.

Study: Cannabinoids Reduce Migraine Frequency

mj_researchThe prolonged daily administration of cannabinoids is associated with a reduction in migraine headache frequency, according to clinical trial data presented at the 3rd Congress of the European Academy of Neurology.

Italian researchers compared the efficacy of oral cannabinoid treatments versus amitriptyline – an anti-depressant commonly prescribed for migraines – in 79 chronic migraine patients over a period of three months. Subjects treated daily with a 200mg dose of a combination of THC and CBD achieved a 40 percent reduction in migraine frequency – a result that was similar to the efficacy of amitriptyline therapy.

Subjects also reported that cannabinoid therapy significantly reduced acute migraine pain, but only when taken at doses above 100mg. Oral cannabinoid treatment was less effective among patients suffering from cluster headaches.

“We were able to demonstrate that cannabinoids are an alternative to established treatments in migraine prevention,” researchers concluded.

Some five million Americans are estimated to experience at least one migraine attack per month, and the condition is the 19th leading cause of disability worldwide.

According to retrospective data published last year in the journal Pharmacotherapy, medical cannabis consumption is often associated with a significant decrease in migraine frequency, and may even abort migraine onset in some patients.

A just published review of several studies and case-reports specific to the use of cannabis and cannabinoids in the journal Cannabis and Cannabinoid Research concludes: “[I]t appears likely that cannabis will emerge as a potential treatment for some headache sufferers.”

An abstract of the study, “Cannabinoids suitable for migraine prevention,” appears online here.

Weekly Legislative Update 7/1/17

revolutionbumperWelcome to this week’s edition of the NORML legislative roundup!

At the federal level, the House Appropriations Committee this week released its 2018 Commerce, Justice, Science (CJS) Appropriations bill, which determines the funding levels for numerous federal agencies, including the Department of Justice. Predictably, the bill does not include language — known as the Rohrabacher-Blumenauer amendment — limiting the Justice Department from taking action against state-sanctioned medical cannabis producers, retailers, or consumers.

The text of this amendment has never been included in the base bill of the CJS Appropriations bill. In every case of its passage, lawmakers have needed to add the language as a separate rider to the legislation and then vote on it on the floor of the House.

This year is no exception. Our allies in Congress anticipate a similar process to take place this fall and they are confident that we will once again be victorious — despite the best efforts of our opponents.

At the state level, the biggest development has been the introduction of Wisconsin Senate Bill 318, to amend state law so that marijuana possession offenses (up to 10 grams) are reduced to a civil offense, punishable by a fine of $100, and no longer have the threat of jail time.

As we prepare for the Fourth of July celebration, it’s always good to have some critical self-reflection about how our democracy is functioning. Our system of government is not perfect – in fact, it is far from it. But for hundreds of years, citizens have organized and struggled to come closer to Thomas Jefferson’s iconic aspiration, “That all men are created equal; that they are endowed by their Creator with certain unalienable Rights; that among these are Life, Liberty and the pursuit of Happiness.

Thomas Jefferson legally grew cannabis. You should be able to as well.

Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

Thanks for all you do and keep fighting,
Justin

Priority Alerts

Federal

Protect Lawful Medical Marijuana Programs: The House Appropriations Committee released its 2018 Commerce, Justice, Science (CJS) Appropriations bill, which determines the funding levels for numerous federal agencies, including the Department of Justice. Predictably, the bill does not include language — known as the Rohrabacher-Blumenauer amendment — limiting the Justice Department from taking action against state-sanctioned medical cannabis producers, retailers, or consumers.

Click here to send a message to your federal elected officials to maintain existing protections from the Justice Department.

Join The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.

Click here to email your Member of Congress to urge them to join the Congressional Cannabis Caucus

California

Legislation is pending, Assembly Bill 1578, to try and limit potential federal interference in the state’s marijuana regulatory laws.

The bill states, “This bill would prohibit a state or local agency, as defined, from taking certain actions without a court order signed by a judge, including using agency money, facilities, property, equipment, or personnel to assist a federal agency to investigate, detain, detect, report, or arrest a person for commercial or noncommercial marijuana or medical cannabis activity that is authorized by law in the State of California and transferring an individual to federal law enforcement authorities for purposes of marijuana enforcement.”

Update: AB-1578 was passed by members of the Senate Public Safety Committee on June 27 by a 5-2 vote.

CA resident? Click here to send your lawmakers a message in support of AB-1578

Delaware

Senate Bill 24, introduced by Senate Majority Leader Margaret Rose Henry to expand the list of qualifying conditions to medical marijuana to include PTSD.

On June 22 Senate Bill 24 was passed the Health & Human Development Committee in statehouse.

DE resident? Click here to send a message to your lawmakers in support of this effort. 

Wisconsin

Senate Bill 318 has been introduced to amend state law so that marijuana possession offenses (up to 10 grams) are reduced to a civil offense, punishable by a fine of $100.

The policy proposed by this bill is line with those of numerous other states, including Nebraska and Ohio. Such a change will save taxpayers money and allow police and the courts to re-prioritize their resources toward addressing more serious crimes.

WI resident? Click here to send a message to your lawmakers in support of decriminalization

Nevada: Licensed Adult Use Marijuana Sales Set To Begin Saturday

Nevada Legalized MarijuanaStarting on Saturday, July 1, specially licensed medical cannabis dispensaries in Nevada will have the opportunity to engage in the retail sale of marijuana to adults.

State tax regulators finalized temporary rules on Monday governing adult use sales. Regulators so far have issued over 80 licenses to business establishments seeking to engage in activities specific to the production, testing, or sale of cannabis to adults.

“Adults in Nevada will now be able to access cannabis in a safe, above ground, regulated environment,” NORML Political Director Justin Strekal said. “To their immense credit, lawmakers expeditiously to implement the will of their voters. Elected officials elsewhere would do well to follow Nevada’s example.”

Adult use sales are anticipated to be limited because of an ongoing legal dispute regarding who may legally transport cannabis to retail stores. Last week, a Carson City judge issued an injunction prohibiting any entity other than liquor distributors from engaging in retail marijuana transport. As a result, retailers will only be able to sell their existing inventory.

“While we applaud Nevada for moving to enact their voter approved legalization initiative in a timely fashion, interested parties must now move quickly and decisively to resolve the pending issues around distribution. If supply remains constrained in the state it will drive up prices and ultimately lead to most retail outlets being entirely out of sellable product for the recreational market.” NORML Executive Director Erik Altieri said. “This will only serve to continue to drive consumers to the black market, the very thing residents voted to demolish, and will deprive the state of needed tax revenue that will instead go to underground operators.”

A majority of voters decided in November in favor of the Regulation and Taxation of Marijuana Act – a voter-initiated regulating the adult use marijuana market. In May, state regulated decided in favor of expediting the timeline for retail marijuana sales from January 1, 2018 to July 1, 2017.

Seven additional states — Alaska, California, Colorado, Maine, Massachusetts, Oregon, and Washington — no longer impose criminal penalties with regard to the adult possession or use of cannabis.

Businesses in the state still do not have protections from the Justice Department, led by militant prohibitionist Attorney General Jeff Sessions, who recently stated marijuana is “only slightly less awful” than heroin.

You can click here to easily send a message to your federal lawmakers in support of pending legislation, HR 1227: The Ending Federal Marijuana Prohibition Act by clicking HERE.

Study: Patients Report Substituting Cannabis For Opioids, Other Pain Medications

medical_mj_shelfPain patients report successfully substituting cannabis for opioids and other analgesics, according to data published online in the journal Cannabis and Cannabinoid Research.

Researchers from the University of California, Berkeley and Kent State University in Ohio assessed survey data from a cohort of 2,897 self-identified medical cannabis patients.

Among those who acknowledged having used opioid-based pain medication within the past six months, 97 percent agreed that they were able to decrease their opiate intake with cannabis. Moreover, 92 percent of respondents said that cannabis possessed fewer adverse side-effects than opioids. Eighty percent of respondents said that the use of medical cannabis alone provided greater symptom management than did their use of opioids.

Among those respondents who acknowledged having recently taken nonopioid-based pain medications, 96 percent said that having access to cannabis reduced their conventional drug intake. Ninety-two percent of these respondents opined that medical cannabis was more effective at treating their condition than traditional analgesics.

Authors concluded: “[M]ore people are looking at cannabis as a viable treatment for everyday ailments such as muscle soreness and inflammation. … [T]his study can conclude that medical cannabis patients report successfully using cannabis along with or as a substitute for opioid-based pain medication.”

The study’s conclusions are similar to those of several others, such as these herehereherehere, and here, finding reduced prescription drug use and spending by those with access to cannabis. Separate studies report an association between cannabis access and lower rates of opioid-related abuse, hospitalizations, traffic fatalities, and overdose deaths.

Full text of the study, “Cannabis as substitute for opioid-based pain medication: patient self-report,” appears online here.

Weekly Legislative Update 6/17/17

revolutionbumperWelcome to this week’s edition of the NORML legislative roundup!

At the Federal level, the biggest news this week was two-fold. First, in a letter made public by Tom Angell of Marijuana Moment, it was revealed that Attorney General Jeff Sessions wrote a private message to Congressional leadership requesting that they lift restrictions on the Department of Justice’s ability to prosecute medical marijuana in states that have legalized. This would overturn years of precedent and could result in the shutdown of lawful state medical programs, depriving patients of the ability to make healthcare decisions with their doctor. This revelation came the day before Deputy Attorney General Rod Rosenstein testified before Congress and stated “The question of whether it’s legal under federal law is resolved because Congress has passed a law — it’s illegal. Scientists have found that there’s no accepted medical use for it.”

Which rolls us right into the second biggest Federal development: the reintroduction of the CARERS Act, which would codify protections for lawful state medical programs. Passage of CARERS 2017 would exempt from federal prosecution those who are engaged in the “production, possession, distribution, dispensation, administration, laboratory testing, recommending use, or delivery of medical marijuana” in instances where these activities comport with state law.

At the state level, New Hampshire Governor Chris Sununu signed HB 157 into law on June 16. The law adds “moderate to severe chronic pain” as a qualifying illness for medical cannabis. The new law takes effect in 60 days.

Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

Thanks for all you do and keep fighting,
Justin

Priority Alerts

Federal
Join The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.

Click here to email your Member of Congress to urge them to join the Congressional Cannabis Caucus

Protecting Patients: Legislation has been reintroduced in the Senate, The Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017, to strengthen protections for those compliant with their state’s medical marijuana laws and to impose various changes to federal law.

Passage of CARERS 2017 exempts from federal prosecution those who are engaged in the “production, possession, distribution, dispensation, administration, laboratory testing, recommending use, or delivery of medical marijuana” in instances where these activities comport with state law. Separate provisions in Act exclude cannabdiol from the federal definition of marijuana, permit VA doctors to authorize medical cannabis access to qualified patients, and remove undue federal barriers to clinical trial research to better assess the safety and efficacy of medical cannabis.

Click here to send a message to your Senators urging them to support and possible co-sponsor the CARERS Act of 2017

Maine
Legislation (LD 764) is before Gov. Paul LePage that will prohibit medical cannabis patients from being denied organ transplants.

The measure “prohibits a transplant evaluator from determining a qualifying patient to be unsuitable to receive an anatomical gift solely because the qualifying patient uses medical marijuana.”

ME resident? Click here to send a message to Gov. LePage urging him to sign the bill. 

Massachusetts
Members of the House put forward amendments to The Regulation and Taxation of Marijuana Act. Among proposed changes to the law would more than double taxes on retail cannabis sales, from 12 percent to as much as 28 percent, strip local control away from municipal voters and unilaterally give local government officials the power to decide whether or not to ban marijuana facilities in their communities, and restrict the kinds of marijuana edibles products that may be sold and purchased by adults.

MA resident? Send a message to your lawmakers telling them to enact Question 4 as passed in a timely manner. 

 

Weekly Legislative Update 6/10/17

revolutionbumperWelcome to this week’s edition of the NORML legislative roundup!

First off, apologies to weekly readers for skipping last week’s update. We held a NORML Legal Committee seminar in Colorado about tactics to continue the fight against prohibition and protect those facing jail and other adverse ramifications of prohibition. You can watch NORML’s Executive Director give the opening welcome HERE and click here to read a write up on it in The Denver Post’s Cannabist HERE.

In the last two weeks, four pieces of legislation that we are supportive of went into law:

Colorado
Senate Bill 17 adds “stress disorders” (PTSD) to the list of debilitating conditions for which a physician may recommend cannabis.

Maryland
House Bill 379 / Senate Bill 949 went into effect May 27 to permit those who received a criminal marijuana possession conviction prior to October 1, 2014, to seek expungement of their records.

Often minor marijuana possession offenders, many of them young people, face the lifelong penalties and stigma associated with having a record, even when the state no longer considers simple possession to be a crime.

Nevada
Assembly Bill 135 eliminates statutes criminalizing the operation of a motor vehicle if a driver has detectable levels of carboxy THC in his/her urine. Carboxy-THC is an non-psychoactive waste product of THC that may be present for days or even weeks post-abstinence. It’s presence in urine is not correlated with psychomotor impairment.

While passage of AB 135 is a step in the right direction, further legislation will continue to be necessary in order to amend Nevada’s traffic safety laws in a manner that no longer inadvertently criminalize responsible adult marijuana consumers in regards to blood testing.

Vermont
SB 16 permits physicians for the first time to recommend medical marijuana to patients with post-traumatic stress, Crohn’s disease, or Parkinson’s disease. The measure also allows physicians to immediately issue medical cannabis recommendations for patients suffering from cancer, a terminal illness, or under hospice care supervision.

Unfortunately, in Montana, SB 333, was signed into law to amend the state’s medical cannabis program, I-182, which voters passed in November.

The measure establishes various rules and regulations regarding the operation of cannabis dispensaries, production facilities, and testing labs. It does not amend the expanded list of qualifying conditions enacted by I-182. However, SB 333 does impose new taxes on medical marijuana gross sales. NORML opposes taxes of medical cannabis. It also reduces the number of seedlings qualified patients are permitted to possess at home from 12 to no more than four. It also imposes limits regarding the total harvest of cannabis permitted per patient.

Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

Thanks for all you do and keep fighting,
Justin

Priority Alerts
Federal
Join The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.

Click here to email your Member of Congress to urge them to join the Congressional Cannabis Caucus

California
Legislation is pending, Assembly Bill 1578, to try and limit potential federal interference in the state’s marijuana regulatory laws.

The bill states, “This bill would prohibit a state or local agency, as defined, from taking certain actions without a court order signed by a judge, including using agency money, facilities, property, equipment, or personnel to assist a federal agency to investigate, detain, detect, report, or arrest a person for commercial or noncommercial marijuana or medical cannabis activity that is authorized by law in the State of California and transferring an individual to federal law enforcement authorities for purposes of marijuana enforcement.”

The majority of Californians desire a legally regulated marijuana market. Passage of this act will limit state or local agencies from working with the federal government to undermine these regulations.

Update: AB 1578 passed the Assembly on June 1 and now moves to the Senate for consideration.

CA resident? Click here to send a message to your state Senator in support of this effort. 

Louisiana
SB 35 provides explicit exemptions from arrest and prosecution for persons lawfully in possession of medical marijuana.

Presently, state regulators are finalizing rules and regulations governing its nascent medical cannabis program, which seeks to permit the production, dispensing, and use of non-herbal preparations of cannabis for qualified patients. Passage of SB 36 amends various criminal statutes to assure that those involved in the program are not inadvertently subject to criminal liability.

Specifically, it provides immunity from arrest for those enrolled in the program who engage in activities related to the purchase or transportation of medical marijuana related products or paraphernalia. It provides further legal protections for pharmacies, producers, and testing laboratories engaged in medical cannabis related activities.

Update: House members amended and passed SB 35 by a vote of 74 to 21 on June 5. Senate members approved the House changes on June 6. The reconciled bill was transmitted to the Governor.

LA resident? Click here to send a message to the Governor in support of SB 35. 

New Hampshire
After nearly a decade of frustration, 2017 is finally the year that New Hampshire voters successfully see marijuana possession decriminalized.

HB 640, will amend criminal penalties for marijuana possession is pending in the House, where lawmakers have overwhelmingly supported such efforts for eight years in a row. However, legislators this year are hopeful that, for the first time, they also have sufficient votes to also clear the Senate.

Update: The House concurred with the amended Senate bill on June 1 and the bill will soon be transmitted to the Governor.

NH resident? Click here to send a message to the Governor thanking him for his support of decriminalization. 

Rhode Island
Sponsors have announced plans to amend their legislation in a manner that would legalize the possession of up to one ounce of cannabis, effective July 1, 2018. The amended legislation would also establish an advisory committee to issue a report to the General Assembly by January 1, 2018 with recommendations regarding how best to establish a system for taxing and regulating marijuana in Rhode Island. Sen. Miller said, “We are prepared to compromise in a significant way, but there must be progress on the issue this year. Our proposal balances the will of the majority of voters who want marijuana to be legal for adults while respecting colleagues who want to slow things down and get the regulations right.”

RI resident? Click here to send a message to your elected officials in support of this effort. 

Other Actions to Take

Massachusetts
Legislation is pending before the House, H 113, to prohibit employers from discriminating against patients who legally consume marijuana during non-work hours. Additional legislation, H 2385, would expand protections for medical marijuana patients so that they may not be discriminated against with regard to housing, higher education, and child custody issues.

Changes in the legal status of marijuana has not been associated with any adverse changes in workplace safety. In fact, a pair of studies from 2016 find that legalization is associated with greater workforce participation and with fewer workplace absences. Most recently, the National Academies of Sciences just-released marijuana and health report found “insufficient evidence” to support an association between cannabis use and occupational accidents or injuries.

MA resident? Click here to send a message to your elected officials in support of this effort. 

New Hampshire
Legislation is pending in the New Hampshire House, HB 215, to establish a commission to study the legalization, regulation, and taxation of marijuana.

Police in New Hampshire arrest some 2,900 individuals annually for simple marijuana possession offenses. The continued criminalization of adult marijuana use is out-of-step with the views of New Hampshire adults, 62 percent of whom now endorse legalizing and regulating cannabis, according to a 2016 WMUR Granite State Poll.

Update: The House has adopted the Senate changes. The bill is expected to be transmitted to the Governor imminently.

NH resident? Click here to send a message to the Governor urging him to sign HB 215

Additionally, multiple bills are pending to expand the pool of patients eligible to qualify for medical marijuana therapy.

In particular, these measures would permit patients with conditions like chronic pain and post-traumatic stress to obtain legal access to marijuana.

NH resident? Click here to contact your elected officials to support patients. 

New York
A pair of bills are pending in the Senate to expand patients’ access to medical cannabis.

Senate Bill 6092 expands the pool of patients eligible for medical cannabis access to include those with Alzheimer’s disease, lupus, rheumatoid arthritis and a number of other debilitating diseases. It also removes arbitrary caps imposed on the amount of THC permitted in oral products.

Senate Bill 6308 allows for additional cannabis providers to operate in the state in order to improve patients’ access.

NY resident? Click here to send a message to your lawmakers in support of these bills. 

Rhode Island
SB 176 is currently pending in the Rhode Island Senate. It amends the state’s Medical Marijuana Act, which currently only permits three medical marijuana dispensaries to operate in the entire state, to permit regulators to license up to six total dispensaries.

In recent years, the total number of registered medical cannabis patients in Rhode Island has nearly doubled to more than 17,000 people. It is necessary for regulators to license additional dispensaries in order to keep up with this increased demand.

RI resident? Click here to send a message to your lawmakers in support of this effort. 

Login | Register

Copyright Top Nug © All Rights Reserved · Top Nug Theme by Ame

PIXSELL8 Pixel Count Remaining